XML 83 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
Equity Compensation
12 Months Ended
Mar. 28, 2015
Equity Compensation [Abstract]  
Equity Compensation

12.      Equity Compensation

 

The Company is currently granting equity awards from the 2006 Stock Incentive Plan (the “Plan”), which was approved by stockholders in July 2006.  The Plan provides for granting of stock options, restricted stock awards, performance awards, phantom stock awards, and bonus stock awards, or any combination of the foregoing.  To date, the Company has granted stock options, restricted stock awards, phantom stock awards (also called restricted stock units), and performance awards (also called market stock units) under the Plan.  Each stock option granted reduces the total shares available for grant under the Plan by one share.  Each full value award granted (including restricted stock awards, restricted stock units and market stock units) reduces the total shares available for grant under the Plan by 1.5 shares.  Stock options generally vest between zero and four years, and are exercisable for a period of ten years from the date of grant.  Generally, restricted stock awards are subject to vesting schedules up to four years.  Restricted stock units are generally subject to vesting from one to three years, depending upon the terms of the grant.  Market stock units are subject to a vesting schedule of three years.

 

The following table summarizes the activity in total shares available for grant (in thousands):

 

 

 

 

 

 

 

 

 

Shares

 

 

Available for

 

 

Grant

Balance, March 31, 2012

 

6,257 

Plans terminated

 

 -

Granted

 

(1,600)

Forfeited

 

468 

Balance, March 30, 2013

 

5,125 

Plans terminated

 

 -

Granted

 

(1,785)

Forfeited

 

207 

Balance, March 29, 2014

 

3,547 

Plans terminated

 

 -

Shares added

 

3,300 

Granted

 

(3,181)

Forfeited

 

230 

Balance, March 28, 2015

 

3,896 

 

As of March 28, 2015, approximately 12.6 million shares of common stock were reserved for issuance under the Plan.

 

Stock Compensation Expense

 

The following table summarizes the effects of stock-based compensation on cost of goods sold, research and development, sales, general and administrative, pre-tax income, and net income after taxes for shares granted under the Plan (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year

 

 

2015

 

 

2014

 

 

2013

Cost of sales

$

747 

 

$

864 

 

$

751 

Research and development

 

11,222 

 

 

10,392 

 

 

10,549 

Sales, general and administrative

 

25,580 

 

 

11,818 

 

 

10,195 

Effect on pre-tax income

 

37,549 

 

 

23,074 

 

 

21,495 

Income Tax Benefit

 

(37,692)

 

 

(8,445)

 

 

(106)

Total share-based compensation expense (benefit) (net of taxes)

 

(143)

 

 

14,629 

 

 

21,389 

Share-based compensation effects on basic earnings per share

$

1.20 

 

$

0.50 

 

$

0.33 

Share-based compensation effects on diluted earnings per share

 

1.15 

 

 

0.48 

 

 

0.32 

Share-based compensation effects on operating activities cash flow

 

(143)

 

 

14,629 

 

 

21,389 

Share-based compensation effects on financing activities cash flow

 

37,692 

 

 

8,445 

 

 

106 

 

The total share based compensation expense included in the table above and which is attributable to restricted stock awards, restricted stock units and market stock units was $34.0 million, $18.6 million, $16.3 million, for fiscal years 2015, 2014, and 2013, respectively.

 

As of March 28, 2015, there was $40.7 million of compensation costs related to non-vested stock options, restricted stock units, and market stock units granted under the Company’s equity incentive plans not yet recognized in the Company’s financial statements.  The unrecognized compensation cost is expected to be recognized over a weighted average period of 1.27 years for stock options, 1.50 years for restricted stock units, and 2.51 years for market stock units.

 

Stock Options 

 

We estimated the fair value of each stock option granted on the date of grant using the Black-Scholes option-pricing model using a dividend yield of zero and the following additional assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

March 28, 2015

 

 

March 29, 2014

 

 

March 30, 2013

 

Expected stock price volatility

 

38.79 

-

42.12

%

 

51.93 

-

54.34

%

 

63.42

%

Risk-free interest rate

 

0.49 

-

0.91

%

 

0.47 

-

0.52

%

 

0.31

%

Expected term (in years)

 

2.15 

-

2.87

 

 

2.46 

-

2.61

 

 

2.46

 

 

The Black-Scholes valuation calculation requires us to estimate key assumptions such as stock price volatility, expected term, risk-free interest rate and dividend yield.  The expected stock price volatility is based upon implied volatility from traded options on our stock in the marketplace.  The expected term of options granted is derived from an analysis of historical exercises and remaining contractual life of stock options, and represents the period of time that options granted are expected to be outstanding after becoming vested.  The risk-free interest rate reflects the yield on zero-coupon U.S. Treasury securities for a period that is commensurate with the expected term assumption.  Finally, we have never paid cash dividends, do not currently intend to pay cash dividends, and thus have assumed a zero percent dividend yield.

 

Using the Black-Scholes option valuation model, the weighted average estimated fair values of employee stock options granted in fiscal years 2015, 2014, and 2013, were $7.26, $10.45, and $20.43, respectively. 

 

During fiscal years 2015, 2014, and 2013, we received a net $5.2 million, $5.1 million, $12.0 million, respectively, from the exercise of 0.7 million, 0.8 million, and 1.7 million, respectively, stock options granted under the Company’s Stock Plan.

 

The total intrinsic value of stock options exercised during fiscal year 2015, 2014, and 2013, was $12.8 million, $12.4 million, and $48.6 million, respectively.  Intrinsic value represents the difference between the market value of the Company’s common stock at the time of exercise and the strike price of the stock option.

 

Additional information with respect to stock option activity is as follows (in thousands, except per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding Options

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

Number

 

 

Exercise Price

Balance, March 31, 2012

 

5,904 

 

$

8.23 

Options granted

 

264 

 

 

37.22 

Options exercised

 

(1,746)

 

 

6.88 

Options forfeited

 

(144)

 

 

12.52 

Options expired

 

 -

 

 

20.25 

Balance, March 30, 2013

 

4,278 

 

$

10.42 

Options granted

 

318 

 

 

23.45 

Options exercised

 

(834)

 

 

6.12 

Options forfeited

 

(10)

 

 

15.33 

Options expired

 

(27)

 

 

19.52 

Balance, March 29, 2014

 

3,725 

 

$

12.42 

Options granted

 

310 

 

 

21.69 

Options exercised

 

(696)

 

 

7.47 

Options forfeited

 

(5)

 

 

19.94 

Options expired

 

(1)

 

 

4.65 

Balance, March 28, 2015

 

3,333 

 

$

14.31 

 

Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable as of March 28, 2015 is as follows (in thousands, except years and per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Number of

 

 

Average

 

Remaining Contractual

 

 

Aggregate

 

 

Options

 

 

Exercise price

 

Term (years)

 

 

Intrinsic Value

Vested and expected to vest

 

3,311 

 

$

14.25

 

5.43

 

$

64,449

Exercisable

 

2,670 

 

$

11.83

 

4.66

 

$

58,150

 

In accordance with U.S. GAAP, stock options outstanding that are expected to vest are presented net of estimated future option forfeitures, which are estimated as compensation costs are recognized.  Options with a fair value of $4.4 million, $4.8 million, and $4.8 million, became vested during fiscal years 2015, 2014, and 2013, respectively.

 

The following table summarizes information regarding outstanding and exercisable options as of March 28, 2015 (in thousands, except per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Weighted

 

 

 

Weighted

 

 

 

 

Contractual Life

 

Average Exercise

 

Number

 

Average

Range of Exercise Prices

 

Number

 

(years)

 

Price

 

Exercisable

 

Exercise Price

$2.82 - $5.53

 

306 

 

3.67 

 

$

5.19 

 

306 

 

$

5.19 

$5.55 - $5.55

 

688 

 

4.53 

 

 

5.55 

 

688 

 

 

5.55 

$5.66 - $7.87

 

568 

 

2.26 

 

 

7.39 

 

568 

 

 

7.39 

$8.06 - $16.25

 

764 

 

5.79 

 

 

15.29 

 

710 

 

 

15.28 

$16.28 - $23.34

 

656 

 

8.29 

 

 

21.48 

 

218 

 

 

20.90 

$23.80 - $38.99

 

351 

 

7.89 

 

 

35.11 

 

180 

 

 

36.49 

 

 

3,333 

 

5.45 

 

$

14.31 

 

2,670 

 

$

11.83 

 

As of March 28, 2015 and March 29, 2014, the number of options exercisable was 2.7 million and 3.0 million, respectively.

 

Restricted Stock Awards

 

The Company periodically grants restricted stock awards (“RSA’s”) to select employees.  The grant date for these awards is equal to the measurement date and the awards are valued as of the measurement date and amortized over the requisite vesting period, which is no more than four years.  A summary of the activity for RSA’s in fiscal years 2015, 2014, and 2013, is presented below (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

 

 

Grant Date

 

Number of

 

 

Fair Value

 

Shares

 

 

(per share)

March 31, 2012

40 

 

$

7.19 

Granted

27 

 

 

28.24 

Vested

(62)

 

 

15.45 

Forfeited

    -

 

 

    -

March 30, 2013

 

 

17.28 

Granted

 -

 

 

    -

Vested

 -

 

 

    -

Forfeited

 -

 

 

    -

March 29, 2014

 

 

17.28 

Granted

 -

 

 

 -

Vested

(5)

 

 

17.28 

Forfeited

 -

 

 

 -

March 28, 2015

 -

 

$

 -

 

 

 

There were no RSA’s outstanding as of March 28, 2015.  RSA’s with a fair value of $86 thousand and $951 thousand became vested during fiscal years 2015 and 2013, respectively.    No RSA’s became vested during fiscal year 2014.

 

Restricted Stock Units

 

Commencing in fiscal year 2011, the Company began granting restricted stock units (“RSU’s”) to select employees.  These awards are valued as of the grant date and amortized over the requisite vesting period.  Generally, RSU’s vest 100 percent on the first to third anniversary of the grant date depending on the vesting specifications.  A summary of the activity for RSU’s in fiscal year 2015, 2014, and 2013 is presented below (in thousands, except year and per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

Shares

 

 

Fair Value

March 31, 2012

1,616 

 

$

16.52 

Granted

864 

 

 

37.26 

Vested

(193)

 

 

20.56 

Forfeited

(216)

 

 

21.46 

March 30, 2013

2,071 

 

 

23.66 

Granted

977 

 

 

22.55 

Vested

(626)

 

 

17.71 

Forfeited

(113)

 

 

25.81 

March 29, 2014

2,309 

 

 

25.26 

Granted

1,887 

 

 

22.04 

Vested

(1,224)

 

 

19.52 

Forfeited

(151)

 

 

26.17 

March 28, 2015

2,821 

 

$

25.57 

 

 

The aggregate intrinsic value of RSU’s outstanding as of March 28, 2015 was $93.9 million.  Additional information with regards to outstanding restricted stock units that are expected to vest as of March 28, 2015, is as follows (in thousands, except year and per share amounts): 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Average

 

Remaining Contractual

 

 

Shares

 

 

Fair Value

 

Term (years)

Expected to vest

 

2,646 

 

$

25.57 

 

1.46 

 

RSU’s outstanding that are expected to vest are presented net of estimated future forfeitures, which are estimated as compensation costs are recognized.  RSU’s with a fair value of $23.9 million and $11.1 million became vested during fiscal years 2015 and 2014, respectivelyThe majority of RSUs that vested in 2015 and 2014 were net settled such that the Company withheld a portion of the shares at fair value to satisfy tax withholding requirements.  In fiscal years 2015 and 2014, the vesting of RSU’s reduced the authorized and unissued share balance by approximately 1.2 million and 0.6 million, respectively.  Total shares withheld and subsequently retired out of the Plan were approximately 0.2 million and 0.2 million, and total payments for the employees’ tax obligations to taxing authorities were $4.6 million and $3.9 million for fiscal years 2015 and 2014, respectively.  A portion of RSUs that vested in fiscal year 2015 and 2014 were cash settled such that the Company received cash from employees in lieu of withholding shares to satisfy tax withholding requirements.  The total amount received from cash settled shares during fiscal year 2015 and 2014 was $0.1 million and $0.2 million, respectively.

 

Market Stock Units

 

In fiscal year 2015, the Company began granting market stock units (“MSU’s”) to select employees. MSU’s vest based upon the relative total shareholder return (“TSR”) of the Company as compared to that of the Index. The requisite service period for these MSU’s is also the vesting period, which is three years.  The fair value of each MSU granted was determined on the date of grant using the Monte Carlo simulation, which calculates the present value of the potential outcomes of future stock prices of the Company and the Index over the requisite service period.  The projection of the stock prices are based on the risk-free rate of return, the volatilities of the stock price of the Company and the Index, the correlation of the stock price of the Company with the Index, and the dividend yield.

 

The fair values estimated from the Monte Carlo simulation were calculated using a dividend yield of zero and the following additional assumptions:

 

 

 

 

 

 

 

Year Ended

 

 

 

March 28,

 

 

 

2015

 

Expected stock price volatility

 

39.65 

%

Risk-free interest rate

 

1.00 

%

Expected term (in years)

 

3.00 

 

 

 

Using the Monte Carlo simulation, the weighted average estimated fair value of the MSU’s granted in fiscal year 2015 was $22.00A summary of the activity for MSU’s in fiscal year 2015 is presented below (in thousands, except year and per share amounts):

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

Shares

 

 

Fair Value

March 29, 2014

 -

 

$

 -

Granted

35 

 

 

22.00 

Vested

 -

 

 

 -

Forfeited

 -

 

 

 -

March 28, 2015

35 

 

$

22.00 

 

The aggregate intrinsic value of MSU’s outstanding as of March 28, 2015 was $1.2 million.  Additional information with regard to outstanding MSU’s that are expected to vest as of March 28, 2015 is as follows (in thousands, except year and per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Average

 

Remaining Contractual

 

 

Shares

 

 

Fair Value

 

Term (years)

Expected to vest

 

35 

 

$

22.00 

 

2.51 

 

 

No MSU’s became vested in 2015.